SCHEMBL25607366

SCHEMBL25607366

COC(=O)c1ccc(-c2cncc(C)n2)cc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 8/20 0.56
CYP11B1 P15538 7/20 0.56
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
MET P08581 6/20 0.44
PIM1 P11309 1/20 0.43
CSNK2A1 P68400 1/20 0.43
PIM3 Q86V86 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
MAPT P10636 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP46A1 Q9Y6A2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25607375 0.85 CYP11B2 (0.57) CYP11B2CYP11B1PIM1CSNK2A1PIM3
SCHEMBL24088755 0.84 CYP11B2 (0.48) CYP11B2CYP11B1NPC1RAB9ASMN1; SMN2
SCHEMBL31676635 0.84 CYP11B2 (0.48) CYP11B2CYP11B1NPC1RAB9ASMN1; SMN2
SCHEMBL22490765 0.84 CYP11B2 (0.44) CYP11B2CYP11B1NPC1RAB9ASMN1; SMN2
SCHEMBL22490772 0.83 NPC1 (0.41) CYP11B2CYP11B1NPC1RAB9ASMN1; SMN2
SCHEMBL21392103 0.82 CTPS1 (0.54) CYP11B2CYP11B1NPC1RAB9ASMN1; SMN2
SCHEMBL21392101 0.82 CTPS1 (0.53) CYP11B2CYP11B1MET
SCHEMBL29489098 0.82 CTPS1 (0.53) CYP11B2CYP11B1MET
SCHEMBL30415999 0.82 CTPS1 (0.54) CYP11B2CYP11B1NPC1RAB9ASMN1; SMN2
SCHEMBL30987732 0.80 ABL1 (0.44) NPC1RAB9ASMN1; SMN2CASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183229-A1 Compounds SYGNATURE DISCOVERY LIMITED (GB) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183229-A1 Compounds UGT1A1, CYP1A1, CYP1B1 CYP11B2 10/4885CYP11B1 9/4885NPC1 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.